International Journal of Oncology

Papers
(The median citation count of International Journal of Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)181
Identification and characterization of slow‑cycling cells in Ewing sarcoma106
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)81
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals72
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway63
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells54
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes53
Role of miR‑181a‑5p in cancer (Review)50
Human‑made electromagnetic fields: Ion forced‑oscillation and voltage‑gated ion channel dysfunction, oxidative stress and DNA damage (Review)48
DNA methylation and breast cancer: A way forward (Review)48
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer44
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer43
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer40
Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells39
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells37
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression36
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)34
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A2034
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol33
MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways32
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition31
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma30
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors29
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma29
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells29
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential29
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin28
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer28
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)28
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)28
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-327
Regulation of gliomagenesis and stemness through acid sensor ASIC1a25
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization25
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway25
Current research status of TNFAIP8 in tumours and other inflammatory conditions (Review)25
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer24
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression23
[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway23
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)22
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation22
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation22
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer21
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)21
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox420
Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells20
[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma20
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells19
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway19
[Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR119
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells19
Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis19
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑118
PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the OCT4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma18
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)18
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)18
Role of miRNA‑122 in cancer (Review)18
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)18
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells17
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review17
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway17
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway17
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)16
Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids16
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells16
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer16
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma16
HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation16
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL316
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy16
Role of DCLK1 in oncogenic signaling (Review)16
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality15
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)15
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells15
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)15
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)15
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma15
Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein15
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway15
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer15
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)15
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer14
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma14
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion14
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α14
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)14
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway14
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)13
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer13
Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review)13
EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021)13
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)13
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP913
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells13
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome13
MicroRNA in adenoid cystic carcinoma (Review)13
Establishment of patient‑derived lung tumorspheres and their response to internal irradiation by Auger electrons12
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)12
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer12
[Retracted] Expression and function of PIM kinases in osteosarcoma12
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells12
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis12
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia12
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)12
[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis12
Roles of salt‑inducible kinases in cancer (Review)12
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway12
lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F312
[Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R312
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer12
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma12
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)11
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway11
Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)11
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)11
Circular RNAs in osteosarcoma: An update of recent studies (Review)11
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling11
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)10
Function of microRNA‑124 in the pathogenesis of cancer (Review)10
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma10
lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway10
Controversial roles of cold‑inducible RNA‑binding protein in human cancer (Review)10
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer10
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells10
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia10
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)10
Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis10
Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells10
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling10
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts10
Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities10
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation10
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation10
Targeting drug resistance in glioblastoma (Review)10
m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling10
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α10
Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation10
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma10
Tumor suppressive functions of WNT5A in rhabdomyosarcoma9
Role of microRNAs in glycolysis in gynecological tumors (Review)9
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)9
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)9
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance9
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H9
[Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer9
P2Y2R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells9
TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway9
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer9
[Corrigendum] SMC1A promotes growth and migration of prostate cancer in vitro and in vivo9
KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity9
Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway9
Everolimus therapy and side‑effects: A systematic review and meta‑analysis8
Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review)8
Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy8
[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway8
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles8
Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer8
circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis8
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway8
[Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells8
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine8
Spine‑specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor‑positive breast cancer by activating glutamine‑dependent mTOR signaling8
[Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids8
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)8
New insights into lipid metabolism and prostate cancer (Review)8
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion8
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)8
Molecular targets of primary cilia defects in cancer (Review)8
Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer8
SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma8
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation8
[Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma8
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer8
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHR8
Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment8
Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma8
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)8
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells8
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway7
Adjusting for comorbidity in observational cancer studies: A systematic review to assess alignment between index and study7
The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review)7
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway7
LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression7
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)7
Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors7
WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG157
Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN97
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)7
Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma7
S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)7
Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)7
[Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression7
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells7
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)7
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)7
Cx32 promotes autophagy and produces resistance to SN‑induced apoptosis via activation of AMPK signalling in cervical cancer7
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review)7
[Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT27
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway7
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)7
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer7
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)7
RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment (Review)7
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer7
Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer6
Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer6
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer6
Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)6
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)6
N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer6
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)6
Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER+ breast cancer cells6
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway6
NADPH oxidase 5 has a crucial role in cellular motility of colon cancer cells6
Potential of antiviral drug oseltamivir for the treatment of liver cancer6
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer6
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation6
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)6
Roles of m6A modification in oral cancer (Review)6
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1low/negative non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy6
DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells6
Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer6
Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review)5
Targeting neddylation as a novel approach to lung cancer treatment (Review)5
An emerging role of radiation‑induced exosomes in hepatocellular carcinoma progression and radioresistance (Review)5
Endoplasmic reticulum stress‑induced cell death as a potential mechanism for targeted therapy in glioblastoma (Review)5
DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions5
‘Reverse Warburg effect’ of cancer‑associated fibroblasts (Review)5
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway5
Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer5
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis5
lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis5
A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M25
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)5
Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis5
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer5
MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia5
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)5
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)5
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth5
Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑75
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal5
CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells5
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA5
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels5
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients5
Long non‑coding RNAs in multiple myeloma (Review)5
Eupalinolide A induces autophagy via the ROS/ERK signaling pathway in hepatocellular carcinoma cells in vitro and in vivo5
N6‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression5
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)5
0.10002708435059